<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurobiol Pain</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol Pain</journal-id>
<journal-title-group>
<journal-title>Neurobiology of Pain</journal-title>
</journal-title-group>
<issn pub-type="epub">2452-073X</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30370343</article-id>
<article-id pub-id-type="pmc">6201239</article-id>
<article-id pub-id-type="publisher-id">S2452-073X(18)30001-1</article-id>
<article-id pub-id-type="doi">10.1016/j.ynpai.2018.01.003</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>RNA-binding proteins as targets for pain therapeutics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>de la Peña</surname>
<given-names>June Bryan</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campbell</surname>
<given-names>Zachary T.</given-names>
</name>
<email>zachary.campbell@utdallas.edu</email>
<xref ref-type="corresp" rid="cor1">⁎</xref>
</contrib>
</contrib-group>
<aff id="af005">Department of Biological Sciences, University of Texas Dallas, Richardson, TX 75080, United States</aff>
<author-notes>
<corresp id="cor1"><label>⁎</label>Corresponding author at: Department of Biological Sciences, 800 W. Campbell Road, RL10 BSB 12.510, Richardson, TX 75080, United States. <email>zachary.campbell@utdallas.edu</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<season>Aug-Dec</season>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>4</volume>
<fpage>2</fpage>
<lpage>7</lpage>
<history>
<date date-type="received">
<day>2</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>25</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract abstract-type="author-highlights" id="ab005">
<title>Highlights</title>
<p>
<list id="l0005" list-type="simple">
<list-item id="o0005">
<label>•</label>
<p id="p0005">Post-transcriptional regulation is linked to the development of pain hypersensitivity.</p>
</list-item>
<list-item id="o0010">
<label>•</label>
<p id="p0010">A growing body of evidence indicates that RNA-binding proteins are involved in pain.</p>
</list-item>
<list-item id="o0015">
<label>•</label>
<p id="p0015">RNA-based inhibitors are a potential new source of pain therapeutics.</p>
</list-item>
</list>
</p>
</abstract>
<abstract id="ab010">
<p>RNA-protein interactions permeate biology. Transcription, translation, processing, and mRNA decay all hinge on widespread use of regulatory information decoded by RNA-binding proteins. The final committed step of protein synthesis, translation, is intimately linked to nociceptor excitability. Understanding the factors that control translation is essential as nociceptor plasticity is a hallmark of persistent pain. Here, we review the growing body of evidence for widespread involvement of RNA-binding proteins in pain. Many of the relevant factors have been implicated in post-transcriptional and translational mechanisms of mRNA control. We propose that recent advances in the development of RNA-based therapeutics provide a potential means to exploit our current understanding of liaisons between RNAs and proteins for therapeutic purposes.</p>
</abstract>
<kwd-group id="kg005">
<title>Keywords</title>
<kwd>RNA-binding proteins</kwd>
<kwd>Pain</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s0005">
<title>Introduction</title>
<p id="p0020">Transcription results in the production of ribonucleic acid (RNA) and RNA can be translated into protein. This framework provides a simplistic view into how instructions present in the genomic blueprint manifest in complex and dynamic patterns of protein expression. The final committed step in this process, translation, is intimately linked to nociceptor plasticity and the development of pain hypersensitivity (<xref ref-type="bibr" rid="b0010">Alvarez et al., 2000</xref>, <xref ref-type="bibr" rid="b0005">Alvarez, 2001</xref>, <xref ref-type="bibr" rid="b0255">Price and Geranton, 2009</xref>, <xref ref-type="bibr" rid="b0180">Khoutorsky et al., 2015</xref>). Understanding the factors that influence translation is important as nociceptor plasticity both requires protein synthesis and is a hallmark of persistent pain (<xref ref-type="bibr" rid="b0110">Ferrari et al., 2013a</xref>).</p>
<p id="p0025">As the essential intermediate in protein synthesis, messenger RNA (mRNA) is subject to regulation at virtually every level. Precise control of mRNA processing, stability, translation, and localization dictates the efficiency, timing, and site of protein production. For instance, mRNA stability spans nearly four orders of magnitude ranging from minutes to months (<xref ref-type="bibr" rid="b0135">Goldstrohm and Wickens, 2008</xref>). Similarly, translation can occur in spatially defined regions of a cell such as the cell body or in axons (<xref ref-type="bibr" rid="b0055">Brittis et al., 2002</xref>, <xref ref-type="bibr" rid="b0050">Bramham and Wells, 2007</xref>). Integral to local translation is polarity in the cytoplasmic distribution of mRNAs (<xref ref-type="bibr" rid="b0215">Medioni et al., 2012</xref>). This information is encoded by cis-acting regulatory elements with variable strength, number, and positioning. The interaction between these elements and their protein partners gives rise to mRNA function and is ultimately the mechanism that trans-acting factors utilize to decode regulatory information.</p>
<p id="p0030">Regulatory sequences and structural elements occur throughout a transcript and serve a crucial role in specification of mRNA function (see <xref ref-type="fig" rid="f0005">Fig. 1</xref>). For instance, translation initiation is generally orchestrated through interactions that require proteins bound to the 5′ 7-methylguanylate (m7G) cap of an mRNA (<xref ref-type="bibr" rid="b0335">Yanagiya et al., 2012</xref>). The cap is bound by a multi-protein complex containing <underline>e</underline>ukaryotic translation <underline>i</underline>nitiation <underline>f</underline>actors (eIF)4A, eIF4G, and eIF4E (collectively referred to as eIF4F) (<xref ref-type="bibr" rid="b0130">Gingras et al., 1999</xref>). eIF4E is the subunit responsible for cap binding and is subject to dynamic regulation through sequestration with protein partners and phosphorylation (<xref ref-type="bibr" rid="b0300">Sonenberg et al., 1978</xref>, <xref ref-type="bibr" rid="b0205">Matsuo et al., 1997</xref>). Adjacent to the m7G cap is the 5′ <underline>u</underline>n<underline>t</underline>ranslated <underline>r</underline>egion (UTR). The UTR serves as a repository for regulatory information including secondary structural elements, <underline>i</underline>nternal <underline>r</underline>ibosomal <underline>e</underline>ntry <underline>s</underline>equences (IRES), <underline>u</underline>pstream <underline>o</underline>pen <underline>r</underline>eading <underline>f</underline>rame<underline>s</underline> (uORFs) and RNA-binding protein motifs. IRES elements bypass the requirement for specific translation factors and thus mediate cap-independent translational control (<xref ref-type="bibr" rid="b0145">Hellen and Sarnow, 2001</xref>). 5′ UTRs can also contain hairpin structures and pseudoknots which make translation less efficient from the main open reading frame. These secondary structures can be unwound by helicases such as eIF4A (<xref ref-type="bibr" rid="b0100">Feoktistova et al., 2013</xref>, <xref ref-type="bibr" rid="b0125">Garcia-Garcia et al., 2015</xref>). The 5′ UTR can also contain uORFs which generally reduce translation of the downstream reading frame. uORFs may encode bioactive peptides as has been recently demonstrated in immunity (<xref ref-type="bibr" rid="b0310">Starck et al., 2016</xref>). Like the 5′ UTR, the 3′ UTR is also resplendent with motifs for regulatory protein complexes. These factors can enhance or reduce protein synthesis, but majority of these mechanisms appear to be repressive – implying that the default status of translation favors protein production. A dynamic feature of mRNA metabolism is modulation of poly-adenosine(A) tail length (<xref ref-type="bibr" rid="b0135">Goldstrohm and Wickens, 2008</xref>). After transcription, the mRNA possesses a long poly(A) tail. This tail can undergo regulated shortening through a process called deadenylation. RNA-binding proteins influence poly(A) tail length through recruitment of cytoplasmic poly(A) polymerases or deadenylases. MicroRNAs (miRNA) can also elicit deadenylation (<xref ref-type="bibr" rid="b0315">Valencia-Sanchez et al., 2006</xref>). Loss of the poly(A) tail can stimulate decapping and decay (<xref ref-type="bibr" rid="b0070">Chen and Shyu, 2011</xref>).<fig id="f0005"><label>Fig. 1</label><caption><p>RNA-protein interactions on a model mRNA. The coding sequence (CDS) is flanked by a 5′ and 3′ untranslated region (UTR). The UTR contains sequences and structures that are bound by proteins such as HuR and CPEB. Additionally, hairpins, IRES, and uORFs in the 5′ UTR can modulate protein expression. The m7G cap and Poly(A) tail are bound by the eIF4F complex and PABP respectively.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<p id="p0035">In this review, we summarize recent progress into conserved mechanisms of mRNA control implicated in pain. We focus first on the trans-acting factors involved in RNA recognition. We describe new potential players based on analysis of cis-acting elements found in key transcripts. Finally, we discuss the potential use of RNA-based inhibitors for understanding underlying mechanisms of chronic pain and as a new source of pain therapeutics.</p>
</sec>
<sec id="s0010">
<title>RNA-binding proteins that are involved in pain</title>
<p id="p0040">Several RNA-binding proteins have been identified to play a role in pain through various animal models of chronic pain conditions (see <xref ref-type="table" rid="t0005">Table 1</xref>). The functions of these RNA-binding proteins range from mRNA cap recognition, stabilization, stimulation, repression, and even decay.<table-wrap id="t0005" position="float"><label>Table 1</label><caption><p>Regulation of RBPs in different models of chronic pain conditions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>RBP</th><th>Biological functions</th><th>Depletion strategy</th><th>Pain model</th><th>Outcome</th><th>Citation</th></tr></thead><tbody><tr><td>eukaryotic translation initiation factor 4E (eIF4E)</td><td>Recognizes and binds the 5′ cap of an mRNA. It is an essential component of the eIF4F complex that promotes translation.</td><td>Knock-in (KI) mutation of the eIF4E phosphorylation site (serine 209) in mice (eIF4E<sup>S209A</sup> mice).</td><td>Mechanical and thermal hyperalgesia induced by pronociceptive (NGF, IL6) and inflammatory (carrageenan) factors, and of injury (SNI) in eIF4E<sup>S209A</sup> mice.<break></break>Assessment of increases in neuronal excitability induced by NGF and IL6.</td><td>Pronociceptive and inflammatory factors produce decreased mechanical and thermal hypersensitivity, decreased affective pain behaviors, and strongly reduced hyperalgesic priming in eIF4E<sup>S209A</sup> mice. Cold hypersensitivity following peripheral nerve injury and NGF- and IL6-induced increases in neuronal excitability were also attenuated in eIF4E<sup>S209A</sup> mice.</td><td><xref ref-type="bibr" rid="b0235">Moy et al. (2017)</xref></td></tr><tr><td>HuD or ELAV Like RNA Binding Protein 4 (Elavl4)</td><td>A member of the Hu family that plays a role in neuronal development and plasticity.</td><td>Intrathecal antisense oligonucleotide (ASO).<break></break>Single injection every 24 h for a total of 3 injections.</td><td>2′,3′-dideoxycytidine (ddC)-evoked painful neuropathy in mice, a model of antiretroviral neuropathy.</td><td>HuD silencing reverted ddC-induced pain hypersensitivity.</td><td><xref ref-type="bibr" rid="b0285">Sanna et al. (2015)</xref></td></tr><tr><td>HuR or ELAV Like RNA Binding Protein 1 (Elavl1)</td><td>Ubiquitously expressed member of the Hu family. Positively regulates the stability of many target mRNAs, including several cytokines, and is involved in the maintenance of inflammation and in the proper functioning of the immune system.</td><td>Intrathecal ASO.<break></break>Single injection every 4 days, for a total of 4 injections.</td><td>Mouse model (female only) of relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE), an experimental model of Multiple Sclerosis.</td><td>ASO treatment completely attenuated hind paw mechanical allodynia and thermal hyperalgesia developed by RR-EAE mice.</td><td><xref ref-type="bibr" rid="b0290">Sanna et al. (2017)</xref></td></tr><tr><td rowspan="4">Cytoplasmic polyadenylation element binding protein (CPEB)</td><td rowspan="4">Promotes the elongation of the poly(A) tail of mRNA by recruiting all the molecular components necessary to catalyze polyadenylation.</td><td rowspan="2">Intrathecal ASO.<break></break>A dose of 40 µg/day for seven consecutive days</td><td>Rats treated with carrageenan and subsequently challenged by prostaglandin E2 (PGE2).</td><td>ASO-treated rats did not show enhanced and prolonged hyperalgesic response to PGE2.</td><td rowspan="2"><xref ref-type="bibr" rid="b0040">Bogen et al. (2012)</xref></td></tr><tr><td>Rats treated with the selective PKCε agonist, ψεRACK, and subsequently challenged by PGE2</td><td>ASO-treated rats did not show hyperalgesic response to PGE2. Priming by ψεRACK, can be prevented but not reversed by CPEB ASO</td></tr><tr><td>Intrathecal ASO.<break></break>A dose of 40 μg/day and was administered for 3 consecutive days</td><td>Neuropathic pain induced by HIV envelope protein gp120 combined with antiretroviral drug (ddC).</td><td>ASO-treated rats displayed reduced mechanical allodynia.</td><td><xref ref-type="bibr" rid="b0165">Iida et al. (2016)</xref></td></tr><tr><td>Cpeb3 gene knockout (Cpeb3-KO)</td><td>Assessment of sensory (thermal and mechanical) and hyperalgesic [Complete Freund’s adjuvant (CFA)-induced inflammatory pain model] responses in Cpeb3-KO mice.</td><td>Cpeb3-KO mice demonstrated hypersensitivity to noxious heat. In the CFA-induced inflammatory pain model, Cpeb3-KO mice showed normal thermal hyperalgesia and transiently enhanced mechanical hyperalgesia.</td><td><xref ref-type="bibr" rid="b0120">Fong et al. (2016)</xref></td></tr><tr><td>Fragile X mental retardation protein (FMRP)</td><td>Binds to mRNAs and is involved in transporting them to distal sites in cells while repressing their translation.</td><td>Fmr1 gene knock-out (Fmr1-KO)</td><td>Mechanical and thermal threshold assessment, formalin-induced nociception, and nerve injury-induced allodynia in Fmr1-KO mice. <italic>In vitro</italic> spinal cord preparation to examine the incidence of wind-up responses (plasticity) in ascending sensory fibers after repetitive C-fiber stimulation.</td><td>Fmr1-KO mice showed decreased responses to ongoing nociception, a delay in the development of peripheral nerve injury-induced allodynia, and a near absence of wind-up responses.</td><td><xref ref-type="bibr" rid="b0260">Price et al. (2007)</xref></td></tr><tr><td>Poly(A) binding protein (PABP)</td><td>PABP binds the poly(A) tail. It protects RNA from deadenylation and stimulates translation initiation by bridging the poly(A) tail to the eIF4F complex.</td><td>PABP inhibition by a chemically modified RNA-based competitive inhibitor (SPOT-ON).</td><td>Mechanical hyperalgesia and priming induced by pro-inflammatory cytokines (NGF or IL6), capsaicin, or incision in mice.</td><td>Local delivery of the PABP SPOT-ON blocked mechanical hyperalgesia induced by either pro-inflammatory cytokines, capsaicin, or incision.</td><td><xref ref-type="bibr" rid="b0030">Barragán-Iglesias et al. (2018)</xref></td></tr></tbody></table></table-wrap></p>
<sec id="s0015">
<title>Cap-binding protein</title>
<p id="p0045">The 5′ m7G cap of an mRNA is bound by the cap-binding protein eIF4E. eIF4E is controlled by protein-partners and phosphorylation. In dorsal root ganglion (DRG) neurons, the pro-inflammatory mediators <underline>n</underline>erve <underline>g</underline>rowth <underline>f</underline>actor (NGF) and <underline>i</underline>nter<underline>l</underline>eukin-<underline>6</underline> (IL-6) promote translation through convergent effects on eIF4F association with the m7G cap (<xref ref-type="bibr" rid="b0220">Melemedjian et al., 2010</xref>). In both cases, nascent protein synthesis is enhanced presumably due to more efficient translation initiation. The kinase, mechanistic/mammalian target of rapamycin (mTOR), promotes cap-dependent translation in part through negative regulation of eIF4E-binding proteins (<xref ref-type="bibr" rid="b0035">Beretta et al., 1996</xref>). mTOR binds to Raptor and other protein partners to form the rapamycin-sensitive mTOR complex 1 (mTORC1), which phosphorylates the eIF4E-binding protein 1 (4E-BP1) allowing the release of eIF4E and formation of the eIF4F complex. Accordingly, one consequence of mTOR inhibition is reduced binding of the eIF4F complex to the m7G cap (<xref ref-type="bibr" rid="b0200">Mathews et al., 2007</xref>). At least three additional lines of evidence suggest that eIF4E activity is relevant to pain. First, systemic dosing of the mTORC1 inhibitor, temsirolimus or Torin1, reduces mechanical and cold hypersensitivity induced by nerve injury in mice (<xref ref-type="bibr" rid="b0245">Obara et al., 2011</xref>). Second, deletion of 4E-BP1 in mice increases mechanical hypersensitivity (<xref ref-type="bibr" rid="b0180">Khoutorsky et al., 2015</xref>). Third and finally, eIF4E phosphorylation promotes the development of nociceptor sensitization (<xref ref-type="bibr" rid="b0235">Moy et al., 2017</xref>), although the precise function of this phosphorylation in enhanced sensitization is not entirely known. Collectively, these experiments illuminate the mechanistic role of eIF4E and the mRNA cap in both acute and persistent pain and has been reviewed in detail elsewhere (<xref ref-type="bibr" rid="b0185">Khoutorsky and Price, 2017</xref>).</p>
</sec>
<sec id="s0020">
<title>ARE-binding proteins</title>
<p id="p0050">Adenylate-uridylate-rich elements (AU-rich elements; AREs) are abundant in the 3′ UTR of mRNAs encoding cytokines and immune-responsive genes (<xref ref-type="bibr" rid="b0065">Chen and Shyu, 1995</xref>). The presence of an ARE has a major impact on mRNA stability (<xref ref-type="bibr" rid="b0295">Shaw and Kamen, 1986</xref>). A variety of proteins facilitate ARE function through direct interactions with mRNA including members of the Hu family (a.k.a. ELAV-like RNA-binding proteins). Mechanistically, Hu proteins can either enhance RNA stability or increase recruitment of the mRNA to the polysome (<xref ref-type="bibr" rid="b0015">Antic et al., 1999</xref>). This is a unique feature of Hu proteins as opposed to other ARE-binding proteins (<xref ref-type="bibr" rid="b0045">Bolognani and Perrone-Bizzozero, 2008</xref>). The ubiquitously expressed member of the family, HuR, has numerous roles related to cellular stress response, while the neuronal members of the family, HuB, HuC, and HuD, serve vital functions in plasticity and brain development (<xref ref-type="bibr" rid="b0150">Hinman and Lou, 2008</xref>). Members of the Hu family appear to facilitate pain in mice. Antisense oligonucleotide (ASO) depletion of HuD via intrathecal injection reverts persistent pain in an animal model of antiretroviral therapy (<xref ref-type="bibr" rid="b0285">Sanna et al., 2015</xref>). Similarly, intrathecal ASO depletion of HuR attenuates mechanical allodynia in a model of autoimmune encephalomyelitis (<xref ref-type="bibr" rid="b0290">Sanna et al., 2017</xref>). These studies suggest that ARE binding proteins and the 3′ UTR promote nociceptive signals likely at the level of RNA stability.</p>
</sec>
<sec id="s0025">
<title><underline>C</underline>ytoplasmic <underline>p</underline>olyadenylation <underline>e</underline>lement <underline>b</underline>inding (CPEB) protein</title>
<p id="p0055">CPEBs are a well-established paradigm in activity-dependent translational regulation (<xref ref-type="bibr" rid="b0270">Richter, 2007</xref>). CPEBs recognize AU-rich sequences in the 3′ UTR and can either repress or stimulate polyadenylation depending on its phosphorylation status (<xref ref-type="bibr" rid="b0160">Hodgman et al., 2001</xref>). CPEB knockdown by intrathecal ASO injection inhibits plasticity in rat hyperalgesic priming models (<xref ref-type="bibr" rid="b0040">Bogen et al., 2012</xref>). Similarly, CPEB depletion reduces mechanical allodynia in an animal model of HIV-related neuropathic pain (<xref ref-type="bibr" rid="b0165">Iida et al., 2016</xref>). Furthermore, mice with deletion of the CPEB3 gene are hypersensitive to noxious heat (<xref ref-type="bibr" rid="b0120">Fong et al., 2016</xref>). These experiments all point to a role of CPEB in nociceptive plasticity. In addition, local activation of the CPEB target CaMKIIα induces hyperalgesic priming and mechanical hyperalgesia (<xref ref-type="bibr" rid="b0115">Ferrari et al., 2013b</xref>, <xref ref-type="bibr" rid="b0330">Wu et al., 2014</xref>). This result suggests a key role for local translation of CaMKIIα in the transition from acute to chronic pain. Given that CPEBs are broad-spectrum pleiotropic regulators with hundreds to thousands of targets, there are undoubtedly additional targets of CPEB in axons (<xref ref-type="bibr" rid="b0105">Fernandez-Miranda and Mendez, 2012</xref>). Their identification will expedite efforts to fully appreciate the full repertoire of potential targets of CPEB and their potential relationship to pain.</p>
</sec>
<sec id="s0030">
<title>Fragile X mental retardation protein (FMRP)</title>
<p id="p0060">The underlying cause of Fragile X syndrome is loss of function of the RNA-binding protein, Fragile X mental retardation protein (FMRP). FMRP regulates synaptic plasticity and binds to a subset of mRNA and directly to the L5 protein on the 80S ribosome (<xref ref-type="bibr" rid="b0020">Ashley et al., 1993</xref>, <xref ref-type="bibr" rid="b0075">Chen et al., 2014</xref>). Fmr1-knockout (Fmr1-KO) mice show decreased responses to ongoing pain and a lag in the onset of injury-induced allodynia (<xref ref-type="bibr" rid="b0260">Price et al., 2007</xref>). mTOR inhibition of formalin and DHPG induced nociception was also impaired in Fmr1-KO mice suggestive of core deficits in translational controls that mediate plasticity (<xref ref-type="bibr" rid="b0260">Price et al., 2007</xref>). In addition, IL-6-induced peripheral sensitization is strongly blunted in Fmr1-KO mice suggestive of an underlying defect in local protein synthesis (<xref ref-type="bibr" rid="b0025">Asiedu et al., 2011</xref>). Given that FMRP is directly bound to ribosomes and that loss of FMRP promotes translation elongation (<xref ref-type="bibr" rid="b0080">Darnell et al., 2011</xref>), an unanswered question remains as to how FMRP affects axonal translation in afferent fibers and if this contributes to abnormal plasticity.</p>
</sec>
<sec id="s0035">
<title>Poly(A) binding proteins (PABPs)</title>
<p id="p0065">In addition to general roles in promoting translation and mRNA stability, PABPs participate in additional mRNA control mechanisms including mRNA storage during cellular stress, mRNA export, mRNA quality control via nonsense-mediated decay, and miRNA-mediated translational repression (<xref ref-type="bibr" rid="b0140">Gorgoni and Gray, 2004</xref>). These functions hinge on the association of PABPs with Poly(A) tails. A growing body of evidence suggests the Poly(A) tail is essential in pain. For instance, the small molecule cordycepin that disrupts polyadenylation inhibits pain plasticity after local delivery in hyperalgesic priming models (<xref ref-type="bibr" rid="b0110">Ferrari et al., 2013a</xref>). Similarly, the end result of CPEB activation is enhanced cytoplasmic poly(A) addition. In recent work, we have shown that RNA-based decoys of the Poly(A) tail, which bind PABP with high affinity <italic>in vitro</italic>, block mechanical hyperalgesia and priming induced by pro-inflammatory cytokines, capsaicin, or incision injury (<xref ref-type="bibr" rid="b0030">Barragán-Iglesias et al., 2018</xref>). PABPs are found in axons and the Poly(A) decoy, when delivered locally, blocks priming. This contributes additional evidence to the notion that disruption of local protein synthesis can impair hyperalgesic priming and suggests that PABPs are required for axonal translation (<xref ref-type="bibr" rid="b0220">Melemedjian et al., 2010</xref>, <xref ref-type="bibr" rid="b0325">Wong et al., 2010</xref>, <xref ref-type="bibr" rid="b0110">Ferrari et al., 2013a</xref>).</p>
</sec>
<sec id="s0040">
<title>Other RBPs with potential roles in pain</title>
<p id="p0070">Additional RBPs are linked, either directly or indirectly, with various pain states, particularly those that contribute in local protein synthesis in sensory neurons (see <xref ref-type="table" rid="t0010">Table 2</xref>). Sensory neurons are vital mediators of nociceptive sensitization. Local protein synthesis in nociceptor terminals or their distal axons has been implicated in promoting hyperexcitability and producing pain sensitization (<xref ref-type="bibr" rid="b0240">Obara et al., 2012</xref>). Inhibition of activity-dependent translation in peripheral axons blocks the development of persistent plasticity as measured by the presence of hyperalgesic priming. This suggests that onset of chronic pain requires regulated local protein synthesis. Thus, understanding basic mechanisms that drive pain sensitization is crucial for the identification of potential targets for chronic pain treatment. Several RNA-binding factors implicated in local translation may play important roles in pain. For instance, the double stranded dsRNA-binding protein, Staufen, is expressed in peripheral sensory neurons and may play a role in axonal mRNA trafficking (<xref ref-type="bibr" rid="b0250">Price et al., 2006</xref>). The zinc finger protein 36 like 2 (ZFP36L2) RBP positively regulates axonal integrity in mature DRG neurons by destabilization of the RE1 Silencing Transcription Factor (REST) (<xref ref-type="bibr" rid="b0060">Cargnin et al., 2014</xref>). Heterogeneous nuclear ribonucleoprotein (hnRNPs) can also be found in axons (hnRNP R) and serve as post-transcriptional regulators of opioid receptor expression (hnRNP H1 and F) (<xref ref-type="bibr" rid="b0305">Song et al., 2012</xref>, <xref ref-type="bibr" rid="b0090">Dombert et al., 2014</xref>). Targeting these axonally localized RBPs might be beneficial for peripheral neuropathic pain.<table-wrap id="t0010" position="float"><label>Table 2</label><caption><p>Other RBPs that might have a role in pain.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>RBP</th><th>Relevant findings</th><th>Citation</th></tr></thead><tbody><tr><td>Staufen (Stau)</td><td>Peripheral sensory neurons express the RNA binding and transport protein, Staufen, and this protein localizes to DRG axons. Stau plays a role in trafficking RNA to sensory axons and, therefore, are attractive targets for therapeutic intervention in sensory dysfunctions, including pain.</td><td><xref ref-type="bibr" rid="b0250">Price et al. (2006)</xref></td></tr><tr><td>Zinc finger protein 36 like 2 (ZFP36L2)</td><td>ZFP36L2 promotes axonal integrity in mature DRG neurons by destabilizing the RE1 Silencing Transcription Factor (REST).</td><td><xref ref-type="bibr" rid="b0060">Cargnin et al. (2014)</xref></td></tr><tr><td rowspan="2">Heterogeneous nuclear ribonucleoproteins (hnRNPs)</td><td>hnRNP R is localized in axons and axon terminals of embryonic and postnatal mouse motoneurons.</td><td><xref ref-type="bibr" rid="b0090">Dombert et al. (2014)</xref></td></tr><tr><td>hnRNP H1 and F function as post-transcriptional repressors of the <italic>mu</italic>-opioid receptor.</td><td><xref ref-type="bibr" rid="b0305">Song et al. (2012)</xref></td></tr><tr><td>Polypyrimidine tract-binding protein 1 (PTBP1)</td><td rowspan="2">PTBP1 and PUM2 binding sequences were found in the extended 3′ UTR sequence of Nav1.8 mRNA present exclusively in the injured axon.</td><td rowspan="2"><xref ref-type="bibr" rid="b0155">Hirai et al. (2017)</xref></td></tr><tr><td>Pumillio homolog 2 (PUM2)</td></tr><tr><td>Argonaut (Ago)</td><td rowspan="3">These RBPs play a role in miRNA biogenesis. miRNAs are promising players in pain management.</td><td rowspan="3"><xref ref-type="bibr" rid="b0210">McDonald and Ajit (2015)</xref></td></tr><tr><td>TAR RNA-binding protein</td></tr><tr><td>Dicer</td></tr></tbody></table></table-wrap></p>
<p id="p0075">Genome-wide approaches suggest that a remarkable amount remains to be uncovered about mechanisms of non-coding RNA, local translation, RNA-decay, and their relationship to pain. For example, noxious stimuli alter patterns of alternative splicing as well as changes in 3′ end utilization (<xref ref-type="bibr" rid="b0095">Donaldson and Beazley-Long, 2016</xref>, <xref ref-type="bibr" rid="b0155">Hirai et al., 2017</xref>). The use of a distal 3′ end isoform of Nav 1.8 mRNA imparts axonal localization after chronic injury. While it is not clear what proteins regulate this differential processing event or axonal localization, cis-acting elements found in the alternate isoform hint at potential roles for Pumillio homolog 2 (Pum2) and polypyrimidine tract-binding protein 1 (PTBP1) (<xref ref-type="bibr" rid="b0155">Hirai et al., 2017</xref>). The underlying mechanisms and functional significance of this phenomenon remain to be elucidated.</p>
<p id="p0080">Injury appears to alter non-coding RNA function. For instance, pain impacts miRNA expression patterns and genetic defects in miRNA processing impact pain thresholds (<xref ref-type="bibr" rid="b0340">Zhao et al., 2010</xref>, <xref ref-type="bibr" rid="b0280">Sakai and Suzuki, 2014</xref>, <xref ref-type="bibr" rid="b0170">Jiangpan et al., 2016</xref>). Along these lines, RBPs that play a role in miRNA biogenesis such as Argonaut (Ago), TAR RNA-binding protein, and Dicer might also contribute to pain (<xref ref-type="bibr" rid="b0210">McDonald and Ajit, 2015</xref>). Long non-coding RNAs and the m6a modification have also been recently implicated in pain further adding to the narrative that diverse RNA-based mechanisms contribute to nociception (<xref ref-type="bibr" rid="b0345">Zhao et al., 2013</xref>, <xref ref-type="bibr" rid="b0320">Weng et al., 2018</xref>).</p>
<p id="p0085">Of the thousands of changes in RNA structure and abundance that are correlated with pain, the challenge becomes establishing causation. Because proteins both regulate and collaborate with RNAs to mediate their function, new approaches that disrupt this interface have a tremendous potential to illuminate our understanding of pain mechanisms <italic>in vivo.</italic></p>
</sec>
</sec>
<sec id="s0045">
<title>New therapeutic tools</title>
<p id="p0090">While the specificity of many RNA-binding proteins is known, rational design of competitive inhibitors is challenging given the unstable nature of RNAs (<xref ref-type="bibr" rid="b0275">Sachs et al., 1987</xref>, <xref ref-type="bibr" rid="b0265">Ray et al., 2013</xref>). Tremendous progress on transcription factors has been made based on DNA mimics of transcription factor consensus binding elements (<xref ref-type="bibr" rid="b0230">Morishita et al., 1998</xref>, <xref ref-type="bibr" rid="b0195">Mann and Dzau, 2000</xref>, <xref ref-type="bibr" rid="b0175">Kang et al., 2008</xref>, <xref ref-type="bibr" rid="b0225">Melemedjian et al., 2014</xref>). RNA is rapidly degraded by exonucleases <italic>in vivo</italic> but can be stabilized through chemical modifications to the 2′ hydroxyl and the phosphodiester backbone (<xref ref-type="bibr" rid="b0085">Dias and Stein, 2002</xref>, <xref ref-type="bibr" rid="b0190">Kole et al., 2012</xref>). We recently demonstrated that such modifications can be introduced into short 12 base RNA oligos. These chemical modifications have minimal effects on equilibrium dissociation constants and increase half-life from hours to over 10 days in serum-containing media (<xref ref-type="bibr" rid="b0030">Barragán-Iglesias et al., 2018</xref>). As a proof of concept for the approach, the compounds, termed <underline>sp</underline>ecificity derived c<underline>o</underline>mpe<underline>t</underline>itive inhibitor <underline>o</underline>ligo<underline>n</underline>ucleotides or SPOT-ONs, were added to axons <italic>in vitro</italic>. The RNAs are taken up and localize throughout axons and the cell body. A SPOT-ON directed against the Poly(A) binding protein with selectivity <italic>in vitro</italic> attenuates translation initiation and functions as a robust anti-hyperalgesic <italic>in vivo</italic>. Because this approach targets the RNA-binding region of a given target, there is no inherent reliance on processing factors from the host. An additional advantage of the SPOT-ON approach is the ability to inhibit entire protein families that bind similar, if not identical sequences, to enact similar functions. By way of comparison, genetic dissection of paralogues gene families is extremely laborious and may result in negative results due to functional compensation. The simplicity of design suggests that this method will be broadly applicable for mechanistic studies of RNA-binding proteins <italic>in vivo</italic>. SPOT-ONs complement existing methods for protein reduction that are suitable for <italic>in vivo</italic> studies including siRNAs and ASOs. These experiments will be critical to elucidate new mechanisms of action with the coveted goal of improved therapies for chronic pain sufferers.</p>
</sec>
<sec id="s0050">
<title>Declaration of interest</title>
<p id="p0100">The authors declare that they have no conflicts of interest.</p>
</sec>
</body>
<back>
<ref-list id="bi005">
<title>References</title>
<ref id="b0005">
<element-citation id="h0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The autonomous axon: a model based on local synthesis of proteins</article-title>
<source/>Biol. Res.
          <volume>34</volume>
<year>2001</year>
<fpage>103</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="pmid">11715201</pub-id>
</element-citation>
</ref>
<ref id="b0010">
<element-citation id="h0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Giuditta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Protein synthesis in axons and terminals: significance for maintenance, plasticity and regulation of phenotype. With a critique of slow transport theory</article-title>
<source/>Prog. Neurobiol.
          <volume>62</volume>
<year>2000</year>
<fpage>1</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">10821981</pub-id>
</element-citation>
</ref>
<ref id="b0015">
<element-citation id="h0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Keene</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells</article-title>
<source/>Genes Dev.
          <volume>13</volume>
<year>1999</year>
<fpage>449</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="pmid">10049360</pub-id>
</element-citation>
</ref>
<ref id="b0020">
<element-citation id="h0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashley</surname>
<given-names>C.T.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Reines</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>FMR1 protein: conserved RNP family domains and selective RNA binding</article-title>
<source/>Science
          <volume>262</volume>
<year>1993</year>
<fpage>563</fpage>
<lpage>566</lpage>
<pub-id pub-id-type="pmid">7692601</pub-id>
</element-citation>
</ref>
<ref id="b0025">
<element-citation id="h0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asiedu</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Tillu</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Melemedjian</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Shy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sanoja</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bodell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Porreca</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Spinal protein kinase M zeta underlies the maintenance mechanism of persistent nociceptive sensitization</article-title>
<source/>J. Neurosci.
          <volume>31</volume>
<year>2011</year>
<fpage>6646</fpage>
<lpage>6653</lpage>
<pub-id pub-id-type="pmid">21543593</pub-id>
</element-citation>
</ref>
<ref id="b0030">
<element-citation id="h0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barragán-Iglesias</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>T.-F.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>Megat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>Z.T.</given-names>
</name>
</person-group>
<article-title>Inhibition of Poly(A)-binding protein with a synthetic RNA mimic reduces pain sensitization in mice</article-title>
<source/>Nat. Commun.
          <volume>9</volume>
<year>2018</year>
<fpage>10</fpage>
<pub-id pub-id-type="pmid">29295980</pub-id>
</element-citation>
</ref>
<ref id="b0035">
<element-citation id="h0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beretta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gingras</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Svitkin</surname>
<given-names>Y.V.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation</article-title>
<source/>EMBO J.
          <volume>15</volume>
<year>1996</year>
<fpage>658</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="pmid">8599949</pub-id>
</element-citation>
</ref>
<ref id="b0040">
<element-citation id="h0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Alessandri-Haber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gear</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Generation of a pain memory in the primary afferent nociceptor triggered by PKCepsilon activation of CPEB</article-title>
<source/>J. Neurosci.
          <volume>32</volume>
<year>2012</year>
<fpage>2018</fpage>
<lpage>2026</lpage>
<pub-id pub-id-type="pmid">22323716</pub-id>
</element-citation>
</ref>
<ref id="b0045">
<element-citation id="h0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolognani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Perrone-Bizzozero</surname>
<given-names>N.I.</given-names>
</name>
</person-group>
<article-title>RNA-protein interactions and control of mRNA stability in neurons</article-title>
<source/>J. Neurosci. Res.
          <volume>86</volume>
<year>2008</year>
<fpage>481</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="pmid">17853436</pub-id>
</element-citation>
</ref>
<ref id="b0050">
<element-citation id="h0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bramham</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Dendritic mRNA: transport, translation and function</article-title>
<source/>Nat. Rev. Neurosci.
          <volume>8</volume>
<year>2007</year>
<fpage>776</fpage>
<lpage>789</lpage>
<pub-id pub-id-type="pmid">17848965</pub-id>
</element-citation>
</ref>
<ref id="b0055">
<element-citation id="h0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brittis</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Flanagan</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>Axonal protein synthesis provides a mechanism for localized regulation at an intermediate target</article-title>
<source/>Cell
          <volume>110</volume>
<year>2002</year>
<fpage>223</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="pmid">12150930</pub-id>
</element-citation>
</ref>
<ref id="b0060">
<element-citation id="h0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cargnin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nechiporuk</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mullendorff</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stumpo</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Blackshear</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Ballas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>An RNA binding protein promotes axonal integrity in peripheral neurons by destabilizing REST</article-title>
<source/>J. Neurosci.
          <volume>34</volume>
<year>2014</year>
<fpage>16650</fpage>
<lpage>16661</lpage>
<pub-id pub-id-type="pmid">25505318</pub-id>
</element-citation>
</ref>
<ref id="b0065">
<element-citation id="h0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Shyu</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>AU-rich elements: characterization and importance in mRNA degradation</article-title>
<source/>Trends Biochem. Sci.
          <volume>20</volume>
<year>1995</year>
<fpage>465</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="pmid">8578590</pub-id>
</element-citation>
</ref>
<ref id="b0070">
<element-citation id="h0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Shyu</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Mechanisms of deadenylation-dependent decay</article-title>
<source/>Wiley Interdiscip. Rev. RNA
          <volume>2</volume>
<year>2011</year>
<fpage>167</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="pmid">21957004</pub-id>
</element-citation>
</ref>
<ref id="b0075">
<element-citation id="h0075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein regulates translation by binding directly to the ribosome</article-title>
<source/>Mol. Cell
          <volume>54</volume>
<year>2014</year>
<fpage>407</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">24746697</pub-id>
</element-citation>
</ref>
<ref id="b0080">
<element-citation id="h0080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darnell</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Van Driesche</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fak</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Licatalosi</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Darnell</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism</article-title>
<source/>Cell
          <volume>146</volume>
<year>2011</year>
<fpage>247</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="pmid">21784246</pub-id>
</element-citation>
</ref>
<ref id="b0085">
<element-citation id="h0085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Antisense oligonucleotides: basic concepts and mechanisms</article-title>
<source/>Mol. Cancer Therapeutics
          <volume>1</volume>
<year>2002</year>
<fpage>347</fpage>
<lpage>355</lpage>
</element-citation>
</ref>
<ref id="b0090">
<element-citation id="h0090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dombert</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sivadasan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Jablonka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sendtner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Presynaptic localization of Smn and hnRNP R in axon terminals of embryonic and postnatal mouse motoneurons</article-title>
<source/>PLoS One
          <volume>9</volume>
<year>2014</year>
<fpage>e110846</fpage>
<pub-id pub-id-type="pmid">25338097</pub-id>
</element-citation>
</ref>
<ref id="b0095">
<element-citation id="h0095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donaldson</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Beazley-Long</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Alternative RNA splicing: contribution to pain and potential therapeutic strategy</article-title>
<source/>Drug Discov. Today
          <volume>21</volume>
<year>2016</year>
<fpage>1787</fpage>
<lpage>1798</lpage>
<pub-id pub-id-type="pmid">27329269</pub-id>
</element-citation>
</ref>
<ref id="b0100">
<element-citation id="h0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feoktistova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tuvshintogs</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity</article-title>
<source/>Proc. Natl. Acad. Sci. U.S.A.
          <volume>110</volume>
<year>2013</year>
<fpage>13339</fpage>
<lpage>13344</lpage>
<pub-id pub-id-type="pmid">23901100</pub-id>
</element-citation>
</ref>
<ref id="b0105">
<element-citation id="h0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Miranda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mendez</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The CPEB-family of proteins, translational control in senescence and cancer</article-title>
<source/>Ageing Res. Rev.
          <volume>11</volume>
<year>2012</year>
<fpage>460</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="pmid">22542725</pub-id>
</element-citation>
</ref>
<ref id="b0110">
<element-citation id="h0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrari</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Bogen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat</article-title>
<source/>J. Pain
          <volume>14</volume>
<year>2013</year>
<fpage>731</fpage>
<lpage>738</lpage>
<pub-id pub-id-type="pmid">23664545</pub-id>
</element-citation>
</ref>
<ref id="b0115">
<element-citation id="h0115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrari</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Bogen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Role of nociceptor alphaCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats</article-title>
<source/>J. Neurosci.
          <volume>33</volume>
<year>2013</year>
<fpage>11002</fpage>
<lpage>11011</lpage>
<pub-id pub-id-type="pmid">23825405</pub-id>
</element-citation>
</ref>
<ref id="b0120">
<element-citation id="h0120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fong</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.S.</given-names>
</name>
</person-group>
<article-title>CPEB3 deficiency elevates TRPV1 expression in dorsal root ganglia neurons to potentiate thermosensation</article-title>
<source/>PLoS One
          <volume>11</volume>
<year>2016</year>
<fpage>e0148491</fpage>
<pub-id pub-id-type="pmid">26915043</pub-id>
</element-citation>
</ref>
<ref id="b0125">
<element-citation id="h0125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Garcia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Frieda</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Feoktistova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>RNA biochemistry. Factor-dependent processivity in human eIF4A DEAD-box helicase</article-title>
<source/>Science
          <volume>348</volume>
<year>2015</year>
<fpage>1486</fpage>
<lpage>1488</lpage>
<pub-id pub-id-type="pmid">26113725</pub-id>
</element-citation>
</ref>
<ref id="b0130">
<element-citation id="h0130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gingras</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Raught</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation</article-title>
<source/>Annu. Rev. Biochem.
          <volume>68</volume>
<year>1999</year>
<fpage>913</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="pmid">10872469</pub-id>
</element-citation>
</ref>
<ref id="b0135">
<element-citation id="h0135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldstrohm</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Wickens</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Multifunctional deadenylase complexes diversify mRNA control</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <volume>9</volume>
<year>2008</year>
<fpage>337</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">18334997</pub-id>
</element-citation>
</ref>
<ref id="b0140">
<element-citation id="h0140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorgoni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>N.K.</given-names>
</name>
</person-group>
<article-title>The roles of cytoplasmic poly(A)-binding proteins in regulating gene expression: a developmental perspective</article-title>
<source/>Brief Funct. Genomic Proteomic
          <volume>3</volume>
<year>2004</year>
<fpage>125</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">15355595</pub-id>
</element-citation>
</ref>
<ref id="b0145">
<element-citation id="h0145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hellen</surname>
<given-names>C.U.</given-names>
</name>
<name>
<surname>Sarnow</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Internal ribosome entry sites in eukaryotic mRNA molecules</article-title>
<source/>Genes Dev.
          <volume>15</volume>
<year>2001</year>
<fpage>1593</fpage>
<lpage>1612</lpage>
<pub-id pub-id-type="pmid">11445534</pub-id>
</element-citation>
</ref>
<ref id="b0150">
<element-citation id="h0150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinman</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Diverse molecular functions of Hu proteins</article-title>
<source/>Cell. Mol. Life Sci.
          <volume>65</volume>
<year>2008</year>
<fpage>3168</fpage>
<lpage>3181</lpage>
<pub-id pub-id-type="pmid">18581050</pub-id>
</element-citation>
</ref>
<ref id="b0155">
<element-citation id="h0155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mulpuri</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ruangsri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spigelman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Aberrant plasticity of peripheral sensory axons in a painful neuropathy</article-title>
<source/>Sci. Rep.
          <volume>7</volume>
<year>2017</year>
<fpage>3407</fpage>
<pub-id pub-id-type="pmid">28611388</pub-id>
</element-citation>
</ref>
<ref id="b0160">
<element-citation id="h0160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodgman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mendez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>CPEB phosphorylation and cytoplasmic polyadenylation are catalyzed by the kinase IAK1/Eg2 in maturing mouse oocytes</article-title>
<source/>Development
          <volume>128</volume>
<year>2001</year>
<fpage>2815</fpage>
<lpage>2822</lpage>
<pub-id pub-id-type="pmid">11526086</pub-id>
</element-citation>
</ref>
<ref id="b0165">
<element-citation id="h0165" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kanda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lubarsky</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Spinal CPEB-mtROS-CBP signaling pathway contributes to perineural HIV gp120 with ddC-related neuropathic pain in rats</article-title>
<source/>Exp. Neurol.
          <volume>281</volume>
<year>2016</year>
<fpage>17</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">27090160</pub-id>
</element-citation>
</ref>
<ref id="b0170">
<element-citation id="h0170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiangpan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Qingsheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhiwen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Emerging role of microRNA in neuropathic pain</article-title>
<source/>Curr. Drug Metab.
          <volume>17</volume>
<year>2016</year>
<fpage>336</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">26467071</pub-id>
</element-citation>
</ref>
<ref id="b0175">
<element-citation id="h0175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>Y.H.</given-names>
</name>
</person-group>
<article-title>CCAAT box is required for the induction of human thrombospondin-1 gene by trichostatin A</article-title>
<source/>J. Cell. Biochem.
          <volume>104</volume>
<year>2008</year>
<fpage>1192</fpage>
<lpage>1203</lpage>
<pub-id pub-id-type="pmid">18275041</pub-id>
</element-citation>
</ref>
<ref id="b0180">
<element-citation id="h0180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khoutorsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bonin</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Sorge</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Gkogkas</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Pawlowski</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Jafarnejad</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Pitcher</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Alain</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Perez-Sanchez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salter</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ribeiro-da-Silva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Koninck</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cervero</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mogil</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Translational control of nociception via 4E-binding protein 1</article-title>
<source/>Elife
          <year>2015</year>
<fpage>4</fpage>
</element-citation>
</ref>
<ref id="b0185">
<element-citation id="h0185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khoutorsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Translational control mechanisms in persistent pain</article-title>
<source/>Trends Neurosci.
          <year>2017</year>
</element-citation>
</ref>
<ref id="b0190">
<element-citation id="h0190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kole</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Krainer</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>RNA therapeutics: beyond RNA interference and antisense oligonucleotides</article-title>
<source/>Nat. Rev. Drug Discov.
          <volume>11</volume>
<year>2012</year>
<fpage>125</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="pmid">22262036</pub-id>
</element-citation>
</ref>
<ref id="b0195">
<element-citation id="h0195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mann</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Dzau</surname>
<given-names>V.J.</given-names>
</name>
</person-group>
<article-title>Therapeutic applications of transcription factor decoy oligonucleotides</article-title>
<source/>J. Clin. Invest.
          <volume>106</volume>
<year>2000</year>
<fpage>1071</fpage>
<lpage>1075</lpage>
<pub-id pub-id-type="pmid">11067859</pub-id>
</element-citation>
</ref>
<ref id="b0200">
<element-citation id="h0200" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Mathews</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hershey</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<chapter-title>Translational Control in Biology and Medicine</chapter-title>
<year>2007</year>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
<publisher-loc>Cold Spring Harbor, NY</publisher-loc>
</element-citation>
</ref>
<ref id="b0205">
<element-citation id="h0205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Gingras</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein</article-title>
<source/>Nat. Struct. Biol.
          <volume>4</volume>
<year>1997</year>
<fpage>717</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="pmid">9302999</pub-id>
</element-citation>
</ref>
<ref id="b0210">
<element-citation id="h0210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonald</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Ajit</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>MicroRNA biology and pain</article-title>
<source/>Prog. Mol. Biol. Transl. Sci.
          <volume>131</volume>
<year>2015</year>
<fpage>215</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">25744675</pub-id>
</element-citation>
</ref>
<ref id="b0215">
<element-citation id="h0215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medioni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mowry</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Besse</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Principles and roles of mRNA localization in animal development</article-title>
<source/>Development
          <volume>139</volume>
<year>2012</year>
<fpage>3263</fpage>
<lpage>3276</lpage>
<pub-id pub-id-type="pmid">22912410</pub-id>
</element-citation>
</ref>
<ref id="b0220">
<element-citation id="h0220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melemedjian</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Asiedu</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Tillu</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Peebles</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ertz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dussor</surname>
<given-names>G.O.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>IL-6- and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex</article-title>
<source/>J. Neurosci.
          <volume>30</volume>
<year>2010</year>
<fpage>15113</fpage>
<lpage>15123</lpage>
<pub-id pub-id-type="pmid">21068317</pub-id>
</element-citation>
</ref>
<ref id="b0225">
<element-citation id="h0225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melemedjian</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Tillu</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Moy</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Asiedu</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dussor</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Local translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity</article-title>
<source/>Mol. Pain
          <volume>10</volume>
<year>2014</year>
<fpage>45</fpage>
<pub-id pub-id-type="pmid">24993495</pub-id>
</element-citation>
</ref>
<ref id="b0230">
<element-citation id="h0230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morishita</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Higaki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ogihara</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Application of transcription factor “decoy” strategy as means of gene therapy and study of gene expression in cardiovascular disease</article-title>
<source/>Circ. Res.
          <volume>82</volume>
<year>1998</year>
<fpage>1023</fpage>
<lpage>1028</lpage>
<pub-id pub-id-type="pmid">9622154</pub-id>
</element-citation>
</ref>
<ref id="b0235">
<element-citation id="h0235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moy</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Khoutorsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asiedu</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Barragan-Iglesias</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Megat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Burgos-Vega</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Melemedjian</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Boitano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vagner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gkogkas</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Pancrazio</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Mogil</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Dussor</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>The MNK-eIF4E signaling axis contributes to injury-induced nociceptive plasticity and the development of chronic pain</article-title>
<source/>J. Neurosci.
          <volume>37</volume>
<year>2017</year>
<fpage>7481</fpage>
<lpage>7499</lpage>
<pub-id pub-id-type="pmid">28674170</pub-id>
</element-citation>
</ref>
<ref id="b0240">
<element-citation id="h0240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obara</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Geranton</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Axonal protein synthesis: a potential target for pain relief?</article-title>
<source/>Curr. Opin. Pharmacol.
          <volume>12</volume>
<year>2012</year>
<fpage>42</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">22033338</pub-id>
</element-citation>
</ref>
<ref id="b0245">
<element-citation id="h0245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obara</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tochiki</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Geranton</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Lumb</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice</article-title>
<source/>Pain
          <volume>152</volume>
<year>2011</year>
<fpage>2582</fpage>
<lpage>2595</lpage>
<pub-id pub-id-type="pmid">21917376</pub-id>
</element-citation>
</ref>
<ref id="b0250">
<element-citation id="h0250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Cervero</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hargreaves</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>The RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axons</article-title>
<source/>Neuroscience
          <volume>141</volume>
<year>2006</year>
<fpage>2107</fpage>
<lpage>2116</lpage>
<pub-id pub-id-type="pmid">16809002</pub-id>
</element-citation>
</ref>
<ref id="b0255">
<element-citation id="h0255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Geranton</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Translating nociceptor sensitivity: the role of axonal protein synthesis in nociceptor physiology</article-title>
<source/>Eur. J. Neurosci.
          <volume>29</volume>
<year>2009</year>
<fpage>2253</fpage>
<lpage>2263</lpage>
<pub-id pub-id-type="pmid">19490023</pub-id>
</element-citation>
</ref>
<ref id="b0260">
<element-citation id="h0260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Rashid</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Millecamps</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sanoja</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Entrena</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Cervero</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR</article-title>
<source/>J. Neurosci.
          <volume>27</volume>
<year>2007</year>
<fpage>13958</fpage>
<lpage>13967</lpage>
<pub-id pub-id-type="pmid">18094233</pub-id>
</element-citation>
</ref>
<ref id="b0265">
<element-citation id="h0265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kazan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Weirauch</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Najafabadi</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gueroussov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Albu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Irimia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matzat</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Yarosh</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Nabet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mecenas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Laishram</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lipshitz</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Piano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Carstens</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Penalva</surname>
<given-names>L.O.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>Q.D.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>T.R.</given-names>
</name>
</person-group>
<article-title>A compendium of RNA-binding motifs for decoding gene regulation</article-title>
<source/>Nature
          <volume>499</volume>
<year>2013</year>
<fpage>172</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="pmid">23846655</pub-id>
</element-citation>
</ref>
<ref id="b0270">
<element-citation id="h0270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>CPEB: a life in translation</article-title>
<source/>Trends Biochem. Sci.
          <volume>32</volume>
<year>2007</year>
<fpage>279</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="pmid">17481902</pub-id>
</element-citation>
</ref>
<ref id="b0275">
<element-citation id="h0275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachs</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Kornberg</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>A single domain of yeast poly(A)-binding protein is necessary and sufficient for RNA binding and cell viability</article-title>
<source/>Mol. Cell. Biol.
          <volume>7</volume>
<year>1987</year>
<fpage>3268</fpage>
<lpage>3276</lpage>
<pub-id pub-id-type="pmid">3313012</pub-id>
</element-citation>
</ref>
<ref id="b0280">
<element-citation id="h0280" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Emerging roles of microRNAs in chronic pain</article-title>
<source/>Neurochem. Int.
          <volume>77</volume>
<year>2014</year>
<fpage>58</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">24905749</pub-id>
</element-citation>
</ref>
<ref id="b0285">
<element-citation id="h0285" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanna</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Peroni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Quattrone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghelardini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Galeotti</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy</article-title>
<source/>Exp. Neurol.
          <volume>267</volume>
<year>2015</year>
<fpage>53</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">25765490</pub-id>
</element-citation>
</ref>
<ref id="b0290">
<element-citation id="h0290" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanna</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Quattrone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Galeotti</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis</article-title>
<source/>Neuropharmacology
          <volume>123</volume>
<year>2017</year>
<fpage>116</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="pmid">28599923</pub-id>
</element-citation>
</ref>
<ref id="b0295">
<element-citation id="h0295" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kamen</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation</article-title>
<source/>Cell
          <volume>46</volume>
<year>1986</year>
<fpage>659</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="pmid">3488815</pub-id>
</element-citation>
</ref>
<ref id="b0300">
<element-citation id="h0300" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Merrick</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Shatkin</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5′-terminal cap in mRNA</article-title>
<source/>Proc. Natl. Acad. Sci. U.S.A.
          <volume>75</volume>
<year>1978</year>
<fpage>4843</fpage>
<lpage>4847</lpage>
<pub-id pub-id-type="pmid">217002</pub-id>
</element-citation>
</ref>
<ref id="b0305">
<element-citation id="h0305" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>P.Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>H.H.</given-names>
</name>
</person-group>
<article-title>Post-transcriptional regulation of mu-opioid receptor: role of the RNA-binding proteins heterogeneous nuclear ribonucleoprotein H1 and F</article-title>
<source/>Cell. Mol. Life Sci.
          <volume>69</volume>
<year>2012</year>
<fpage>599</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="pmid">21739230</pub-id>
</element-citation>
</ref>
<ref id="b0310">
<element-citation id="h0310" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starck</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shodiya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yahiro</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Martins-Green</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shastri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Translation from the 5′ untranslated region shapes the integrated stress response</article-title>
<source/>Science
          <volume>351</volume>
<year>2016</year>
<comment>aad3867</comment>
</element-citation>
</ref>
<ref id="b0315">
<element-citation id="h0315" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valencia-Sanchez</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hannon</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Control of translation and mRNA degradation by miRNAs and siRNAs</article-title>
<source/>Genes Dev.
          <volume>20</volume>
<year>2006</year>
<fpage>515</fpage>
<lpage>524</lpage>
<pub-id pub-id-type="pmid">16510870</pub-id>
</element-citation>
</ref>
<ref id="b0320">
<element-citation id="h0320" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cassin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S.Z.H.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dore</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Epitranscriptomic m(6)A regulation of axon regeneration in the adult mammalian nervous system</article-title>
<source/>Neuron
          <volume>97</volume>
<issue>313–325</issue>
<year>2018</year>
<fpage>e316</fpage>
</element-citation>
</ref>
<ref id="b0325">
<element-citation id="h0325" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>Y.Y.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duffin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Barthet-Barateig</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Clemens</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>de Moor</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction</article-title>
<source/>J. Biol. Chem.
          <volume>285</volume>
<year>2010</year>
<fpage>2610</fpage>
<lpage>2621</lpage>
<pub-id pub-id-type="pmid">19940154</pub-id>
</element-citation>
</ref>
<ref id="b0330">
<element-citation id="h0330" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rattner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Smallwood</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Erlanger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wheelan</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Nathans</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease</article-title>
<source/>Neuron
          <volume>81</volume>
<year>2014</year>
<fpage>103</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="pmid">24411735</pub-id>
</element-citation>
</ref>
<ref id="b0335">
<element-citation id="h0335" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanagiya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suyama</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Svitkin</surname>
<given-names>Y.V.</given-names>
</name>
<name>
<surname>Aza-Blanc</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Imataka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mikami</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martineau</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ronai</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Translational homeostasis via the mRNA cap-binding protein, eIF4E</article-title>
<source/>Mol. Cell
          <volume>46</volume>
<year>2012</year>
<fpage>847</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="pmid">22578813</pub-id>
</element-citation>
</ref>
<ref id="b0340">
<element-citation id="h0340" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Momin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cendan</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Shepherd</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Asante</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bethry</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Nassar</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Abrahamsen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dickenson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cobb</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Merkenschlager</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>J.N.</given-names>
</name>
</person-group>
<article-title>Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds</article-title>
<source/>J. Neurosci.
          <volume>30</volume>
<year>2010</year>
<fpage>10860</fpage>
<lpage>10871</lpage>
<pub-id pub-id-type="pmid">20702715</pub-id>
</element-citation>
</ref>
<ref id="b0345">
<element-citation id="h0345" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Atianjoh</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>Y.X.</given-names>
</name>
</person-group>
<article-title>A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons</article-title>
<source/>Nat. Neurosci.
          <volume>16</volume>
<year>2013</year>
<fpage>1024</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="pmid">23792947</pub-id>
</element-citation>
</ref>
</ref-list>
<ack id="ak005">
<title>Acknowledgements</title>
<p>This work was supported by <funding-source id="gp005">National Institutes of Health</funding-source> grants R01NS100788 (ZC) and startup funds provided by the <funding-source id="gp010">University of Texas-Dallas</funding-source> (ZC).</p>
</ack>
</back>
</article>
</pmc-articleset>